|
General Information
|
|
|
Product
|
PGAP3 Peptide
|
|
Description
|
Antigenic Blocking Peptide Post-GPI attachment to proteins 3 N-epitope
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 1-50 on human PGAP3 protein.
|
|
Accession #
|
GenBank: BC010652
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
N-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q96FM1
|
|
Overview
|
Involved in lipid remodeling steps of GPI-anchor maturation. Remodeling steps consist in the generation of 2 saturated fatty chains at the sn-2 position of GPI-anchor proteins.
|
|
Molecular Function
|
Hydrolase activity, acting on ester bonds, GPI-anchor biosynthesis
|
|
Subcellular Location
|
Golgi apparatus; Endoplasmic reticulum; Membrane
|
|
Expression
|
Ubiqutously expressed; highest levels in thyroid in placenta
|
|
Structure
|
Belongs to PGAP3 family
|
|
Alternative Nomenclature
|
AGLA546 antibody
CAB2 antibody
Gene coamplified with ERBB2 protein antibody
hCOS16 antibody
MGC9753 antibody
PER1 antibody
Per1 like domain containing 1 antibody
PERLD1 antibody
Post GPI attachment to proteins 3 antibody
PP1498 antibody
|
| |
|
PGAP3 Antibody
PGAP3 Antibody FITC
PGAP3 Antibody BIOTIN
PGAP3 Positive Control
